RenovoRx Files Form D for Exempt Securities Offering
Ticker: RNXT · Form: D · Filed: Apr 9, 2026 · CIK: 0001574094
Sentiment: neutral
Topics: exempt-offering, securities, capital-raise
TL;DR
RenovoRx filed a D for a securities offering, details TBD.
AI Summary
RenovoRx, Inc. filed a Form D on April 9, 2026, to announce an exempt offering of securities. The filing does not specify the dollar amount of the offering or the securities being offered, but it indicates the company's business is in Pharmaceutical Preparations.
Why It Matters
This filing signals RenovoRx, Inc. is seeking capital through an exempt offering, which could fund its operations or expansion in the pharmaceutical sector.
Risk Assessment
Risk Level: medium — Form D filings indicate a capital raise, but the lack of specific details on the offering size and terms makes assessing the immediate risk level difficult.
Key Players & Entities
- RenovoRx, Inc. (company) — Filer of the Form D
- 2026-04-09 (date) — Filing date of the Form D
- 2834 (industry_code) — SIC code for Pharmaceutical Preparations
FAQ
What is the purpose of this Form D filing?
The Form D filing by RenovoRx, Inc. on April 9, 2026, is to notify the SEC of an exempt offering of securities.
What is the CIK number for RenovoRx, Inc.?
The CIK number for RenovoRx, Inc. is 0001574094.
What is the business address of RenovoRx, Inc.?
The business address for RenovoRx, Inc. is 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040.
What is the SIC code associated with RenovoRx, Inc.?
The SIC code for RenovoRx, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
When was this Form D filing accepted by the SEC?
This Form D filing was accepted by the SEC on April 9, 2026, at 10:19:11.
Filing Details
This Form D (Form D) was filed with the SEC on April 9, 2026 regarding RenovoRx, Inc. (RNXT).